Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 16;2(1):vdaa038. doi: 10.1093/noajnl/vdaa038

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — (A) MR images of baseline (BL) and follow-up MRI of a lung cancer patient with a partial response after initiation of bevacizumab-based treatment. Partial response is seen both on FLAIR (upper row) and T1-weighted (lower row) images. (B and C) MR imaging examples of patients with breast cancer (B) and colorectal cancer (C) showing partial response on FLAIR and complete response on T1-weighted images after Gd-contrast administration (B) on follow-up MRI. Note that the tumor volume (central core) and perifocal edema can be differentiated on FLAIR images.